Skip to main content
It looks like you're using Internet Explorer 11 or older. This website works best with modern browsers such as the latest versions of Chrome, Firefox, Safari, and Edge. If you continue with this browser, you may see unexpected results.
COVID-19 - PPE ; vaccines
Executive Order on America’s Supply Chains
Pres. Biden, 2/24/21 - within 100 days, submit reports -- "...identifying risks in the semiconductor manufacturing and advanced packaging supply chains" and ..."identifying risks in the supply chain for high-capacity batteries" and..."identifying risks in the supply chain for critical minerals and other identified strategic materials".
Pathway to Protection: Expanding Availability of COVID-19 Vaccines"
# of doses to be manufactured, where, and when - in the US - by July. Congressional hearing; links to prepared testimony by executives of the 3 manufacturers of COVID-19 vaccine, Feb. 23, 2021
Clorox won't have enough disinfecting wipes until 2021, its CEO says
As reported in Reuters, 8/4/20. Note that the product is made with polyester spunlace, which is in short supply because that is also used to make PPE.
U.S. Covid Vaccine Supply: How to Make Sense of Those Confusing Numbers
New York Times online, 1/21/21. Notes the production capabilities of moderna and Pfizer (collectively, 12-18 million doses per week).
Covid-19: China Medical Supply Chains and Broader Trade Issues
Congressional Research Service (CRS) report, released 4/6/20.
The Untold Story of the N95 Mask
From Fast Company periodical, March 24, 2020.
How do you make more masks yesterday?
3M and the N95 mask. Cover story, from Bloomberg Business Week 3/30/20.
Supply Chain Considerations for COVID-19 Vaccine Manufacturing
3-pg. summary from the Congressional Research Service, Nov. 23, 2020.